Abstract 2879: Intra-tumoral microbiota and host genotype cooperatively shape neutrophil antitumor activity in colorectal cancer

Abstract Colorectal cancer (CRC) represents a major cause of cancer related death worldwide. Defined genetic alterations are known to underlie CRC oncogenesis. However, in the last decades a critical role of the composition of tumor microenvironment has also been recognized. While tumor infiltration by T lymphocytes has been consistently recognized to predict improved clinical outcome, the role of tumor-associated neutrophils (TANs) in CRC is still debated.CRC develops in a microbiota-rich environment, and barrier dysfunction allows bacterial translocation into the mucosa. Neutrophils, as first responders to bacteria, may interact with tumor-infiltrating bacteria. However, the functional outcome and prognostic relevance of these interactions have not been thoroughly investigated. Here we unravel that TAN recruitment and functions are modulated by intra-tumoral microbiota and only defined bacterial species are able to unleash TANs’ antitumor potential. Fusobacterium nucleatum (Fn) promotes expression of neutrophil-recruiting chemokines in tumor cells and enhances neutrophil migration more efficiently than Bacteroides fragilis (Bf). Importantly, Fn, but not Bf, triggers neutrophils to release cytotoxic proteins showing tumoricidal activity in vitro and in xenograft models. Mechanistically, these antitumor effects are elicited upon Fn binding to an activatory receptor (R-a) expressed on neutrophils but are impaired upon R-a blockade or in neutrophils from donors carrying a R-a loss-of-function polymorphism. Supporting these findings, in human CRCs, elevated Fn loads, high TANs densities, and expression of wild-type, but not polymorphic, R-a allele, correlate with improved patient survival. Our findings identify microbiota composition and host genetic background as critical determinants of TAN functional profiles and offer insights into neutrophil-targeted therapeutic strategies in CRC. Citation Format: Elisa Sorrenti, Valeria Governa, Davide Bressan, Nicolo' Formaggio, Bianca Calì, Camilla Basso, Martina Villa, Giuseppe Sconocchia, Klaus-Peter Janssen, Milo Frattini, Fulvio Chiacchiera, Jean-Philippe Theurillat, Sara De Dosso, Luigi M. Terracciano, Lubor Borsig, Giulio C. Spagnoli, Dimitrios Christoforidis, Giandomenica Iezzi. Intra-tumoral microbiota and host genotype cooperatively shape neutrophil antitumor activity in colorectal cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 2879.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2026-04-03
DOI
https://doi.org/10.1158/1538-7445.am2026-2879
Primary Topic
Cancer Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 2879: Intra-tumoral microbiota and host genotype cooperatively shape neutrophil antitumor activity in colorectal cancer

Jean‐Philippe Theurillat, Giandomenica Iezzi, Bianca Calì, Fulvio Chiacchiera et al.
Cancer Research
Cancer Research and Treatments
article

Abstract 2879: Intra-tumoral microbiota and host genotype cooperatively shape neutrophil antitumor activity in colorectal cancer

Jean‐Philippe Theurillat, Giandomenica Iezzi, Bianca Calì, Fulvio Chiacchiera, Giulio C. Spagnoli, Camilla Basso, Valeria Governa, Lubor Borsig, Giuseppe Sconocchia, Sara De Dosso, Klaus‐Peter Janssen, Elisa Sorrenti, Davide Bressan, Martina Villa, Nicolo' Formaggio, Dimitrios Christoforidis, Milo Frattini, Luigi M. Terracciano
article en

Abstract

Abstract Colorectal cancer (CRC) represents a major cause of cancer related death worldwide. Defined genetic alterations are known to underlie CRC oncogenesis. However, in the last decades a critical role of the composition of tumor microenvironment has also been recognized. While tumor infiltration by T lymphocytes has been consistently recognized to predict improved clinical outcome, the role of tumor-associated neutrophils (TANs) in CRC is still debated.CRC develops in a microbiota-rich environment, and barrier dysfunction allows bacterial translocation into the mucosa. Neutrophils, as first responders to bacteria, may interact with tumor-infiltrating bacteria. However, the functional outcome and prognostic relevance of these interactions have not been thoroughly investigated. Here we unravel that TAN recruitment and functions are modulated by intra-tumoral microbiota and only defined bacterial species are able to unleash TANs’ antitumor potential. Fusobacterium nucleatum (Fn) promotes expression of neutrophil-recruiting chemokines in tumor cells and enhances neutrophil migration more efficiently than Bacteroides fragilis (Bf). Importantly, Fn, but not Bf, triggers neutrophils to release cytotoxic proteins showing tumoricidal activity in vitro and in xenograft models. Mechanistically, these antitumor effects are elicited upon Fn binding to an activatory receptor (R-a) expressed on neutrophils but are impaired upon R-a blockade or in neutrophils from donors carrying a R-a loss-of-function polymorphism. Supporting these findings, in human CRCs, elevated Fn loads, high TANs densities, and expression of wild-type, but not polymorphic, R-a allele, correlate with improved patient survival. Our findings identify microbiota composition and host genetic background as critical determinants of TAN functional profiles and offer insights into neutrophil-targeted therapeutic strategies in CRC. Citation Format: Elisa Sorrenti, Valeria Governa, Davide Bressan, Nicolo' Formaggio, Bianca Calì, Camilla Basso, Martina Villa, Giuseppe Sconocchia, Klaus-Peter Janssen, Milo Frattini, Fulvio Chiacchiera, Jean-Philippe Theurillat, Sara De Dosso, Luigi M. Terracciano, Lubor Borsig, Giulio C. Spagnoli, Dimitrios Christoforidis, Giandomenica Iezzi. Intra-tumoral microbiota and host genotype cooperatively shape neutrophil antitumor activity in colorectal cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 2879.

Cancer ResearchVol. 86(7_Supplement)
Humanitas University (IT), University of Basel (CH), University of Trento (IT), University of Zurich (CH), Ente Ospedaliero Cantonale (CH), Institute of Oncology Research (CH), Istituto di Farmacologia Traslazionale (IT), Istituto Cantonale di Patologia (CH), National Research Council (IT), Università della Svizzera italiana (CH), Technical University of Munich (DE)
Good health and well-being
Openalex Percentile: Top 32%
Cancer Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.